Hetal Vachhani

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Curcumin enhances the effects of 5‐fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF‐1R

Bhaumik B. Patel, Radha Sengupta, Sadia Qazi et al. · International Journal of Cancer · 2007 · 209 citations

Medicine, Oncology, Pharmacology +15

Education level, not health literacy, associated with information needs for patients with cancer

Robin K. Matsuyama, Maureen Wilson-Genderson, Laura Kuhn et al. · Patient Education and Counseling · 2011 · 103 citations

Public Health, Health Education, Oncology +16

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

Harry D. Bear, Xiaoyan Deng, Dipankar Bandyopadhyay et al. · Journal for ImmunoTherapy of Cancer · 2025 · 16 citations · Full text

Life Sciences, Immunology, Oncology +17